ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,709.54
      0.01%
      US Tech 100
      19,244.40
      -0.17%
      Dow Jones
      42,196.52
      0.00%
      Brent Oil
      75.295
      0.91%
      Bitcoin
      61,011.10
      0.64%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Tourmaline Bio Inc (TRML) Quote

      Tourmaline Bio Inc

      Tourmaline Bio Inc (TRML)

      NASDAQ
      26.50
      0.27
      (1.03%)
      Closed October 02 4:00PM
      Delayed by 15 minutes
      26.50
      0.00
      ( 0.00% )
      Pre Market: 7:20AM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      26.50
      Bid
      26.21
      Ask
      28.00
      Volume
      4
      0.00 Day's Range 0.00
      9.18 52 Week Range 48.31
      Market Cap
      679.496M
      Previous Close
      26.50
      Open
      -
      Last Trade
      2
      @
      27.12
      Last Trade Time
      07:00:00
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      191,812
      Shares Outstanding
      25,641,363
      Dividend Yield
      -
      PE Ratio
      -16.13
      Earnings Per Share (EPS)
      -1.64
      Revenue
      -
      Net Profit
      -42.12M

      About Tourmaline Bio Inc

      Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and ... Talaris Therapeutics Inc is a late-clinical stage biotechnology company. It is developing transformative cell therapies with the potential to eliminate the burden of chronic immunosuppression for organ transplant recipients as well as induce durable remissions in patients with severe autoimmune and immune-mediated disorders. Show more

      Sector
      Biological Pds,ex Diagnstics
      Industry
      Biological Pds,ex Diagnstics
      Website
      talaristx.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      -
      Tourmaline Bio Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker TRML. The last closing price for Tourmaline Bio was $26.50. Over the last year, Tourmaline Bio shares have traded in a share price range of $ 9.18 to $ 48.31.

      Tourmaline Bio currently has 25,641,363 shares outstanding. The market capitalization of Tourmaline Bio is $679.50 million. Tourmaline Bio has a price to earnings ratio (PE ratio) of -16.13.

      Ask ADVFN Intelligence (AI)

      TRML Latest News

      More News

      Form 8-K - Current report

      September 11 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      September 05 2024
      Edgar (US Regulatory)

      Tourmaline Bio to Present at Upcoming Investor Conferences

      NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

      September 03 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      August 22 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      August 20 2024
      Edgar (US Regulatory)

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      August 08 2024
      Edgar (US Regulatory)

      Form 8-K - Current report

      August 08 2024
      Edgar (US Regulatory)

      Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights

      – First patient dosed in May 2024 in Phase 2 TRANQUILITY trial evaluating pacibekitug (TOUR006) in patients with high cardiovascular risk – – On track to initiate a pivotal Phase 3 trial...

      August 08 2024
      GlobeNewswire Inc.

      Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024

      Phase 2 TRANQUILITY trial is evaluating the high-sensitivity C-reactive protein (hs-CRP)-lowering effect, safety, tolerability, and pharmacokinetics (PK) of quarterly and monthly subcutaneous...

      August 02 2024
      GlobeNewswire Inc.

      Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer

      NEW YORK, June 27, 2024 (GLOBE NEWSWIRE) -- Tourmaline Bio, Inc. (Tourmaline) (NASDAQ: TRML), a late-stage clinical biotechnology company developing transformative medicines to dramatically...

      June 27 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      11.254.950495049525.2527.4523.8542831925.84012577CS
      410.1361.881490531516.3727.4515.235429424223.03668428CS
      1212.3587.279151943514.1527.4513.0319181219.49187431CS
      264.9522.96983758721.5527.4512.1226756416.82909271CS
      5216.18156.78294573610.3248.319.1826110222.69412098CS
      15616.18156.78294573610.3248.319.1826110222.69412098CS
      26016.18156.78294573610.3248.319.1826110222.69412098CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      PEGYPineapple Energy Inc
      $ 0.183
      (59.27%)
      		66.05M
      BDSXBiodesix Inc
      $ 2.65
      (51.43%)
      		51
      ELABElevai Labs Inc
      $ 0.111
      (30.28%)
      		37.21M
      MLGOMicroAlgo Inc
      $ 0.3998
      (28.97%)
      		27.84M
      WHLRWheeler Real Estate Investment Trust Inc
      $ 17.10
      (27.71%)
      		992.02k
      KXINKaixin Holdings
      $ 0.2728
      (-20.26%)
      		6.41M
      DUOFangDD Network Group Ltd
      $ 3.54
      (-19.18%)
      		1.51M
      HOLOMicroCloud Hologram Inc
      $ 0.283
      (-17.73%)
      		3.74M
      WINTWindtree Therapeutics Inc
      $ 1.20
      (-16.67%)
      		177.35k
      MTCMMTec Inc
      $ 0.6449
      (-15.91%)
      		1.49M
      PEGYPineapple Energy Inc
      $ 0.183
      (59.27%)
      		66.05M
      ELABElevai Labs Inc
      $ 0.111
      (30.28%)
      		37.21M
      MLGOMicroAlgo Inc
      $ 0.3998
      (28.97%)
      		27.84M
      CDTConduit Pharmaceuticals Inc
      $ 0.118
      (24.21%)
      		21.76M
      KXINKaixin Holdings
      $ 0.2728
      (-20.26%)
      		6.41M

      TRML Discussion

      View Posts
      Monksdream Monksdream 6 months ago
      TRML over $20
      👍️0

      Your Recent History

      NASDAQ
      TRML
      Tourmaline Bio
      NASDAQ
      CYN
      CYNGN
      Delayed Upgrade Clock